Electrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has property to activate electrical impulse and transmit signal to electrodes of device, which causes depolarization and in turn reduces pain and improves muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.

Market Dynamics

Increasing prevalence of neurological disorders, which in turn causes muscle weakness is expected to propel electrical stimulation devices market growth. According to Neurology Today Journal, November 2017, neurological diseases are the world’s largest cause of disability-adjusted life years (DALYs) and an estimated 9.5 million deaths were due to the condition in 2015. Moreover, advantages of electrical stimulation devices of pain management in preoperative and postoperative surgery procedures are expected to boost the Electrical Stimulation Devices Market growth.

The global electrical stimulation devices market size was valued at US$ 3,956.0 million in 2017, and is expected to exhibit a CAGR of 4.7 % over the forecast period (2018 – 2026).

Increasing incidences of spinal injuries is expected to propel growth of the electrical stimulation devices market

Electrical stimulation devices are used in preoperative and postoperative pain management in patients with spinal injuries. High incidence of spinal injuries caused due to accidents, falls or violence is expected to propel demand for spinal surgeries, which in turn is expected to drive the market growth. According to World Health Organization (WHO) factsheet in 2018, annually there are around 37.3 million falls, which require medical attention, whereas about 646,000 individuals die each year, from falls globally.

Moreover, increasing incidences of neurological disorders such as Alzheimer’s disease and trauma associated with spinal injuries is expected to propel growth of the electrical stimulation devices market over the forecast period. For instance, in August 2012, National Center for Biotechnology Information (NCBI) stated Alzheimer’s disease as the most frequent cause of dementia in Western societies and estimated around 5.5 million cases of the disease in the U.S., and 24 million globally.

Key Players

Major players operating in the global electrical stimulation devices market include Boston Scientific Corporation, BTL Industries, Inc., Cyberonics, Inc., DJO Global, Inc., Medtronic plc., Nevro Corporation., NeuroMetrix, Inc., St. Jude Medical, Inc., Uroplasty, Inc. (Cogentix Medical), and Zynex, Inc.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/2486

Increasing prevalence of chronic diseases in North America is expected to bolster the market growth

North America holds dominant position in the global electrical stimulation devices market, owing to high prevalence of chronic diseases. According to National Center for Biotechnology Information (NCBI), March 2018, an estimated 45%, or around 33 million Americans were diagnosed by at least one chronic disease.

Moreover, rise in geriatric population, who are highly susceptible to pain, is expected to bolster the market growth over the forecast period.

According to American Psychological Association, 2014 report, around 40 million people over the age 65 years account for 14% of total population and around 60% to 75% of people over age 65 years are diagnosed with persistent pain.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]